Learn More
The need for evidence-based medicine, including comparative effectiveness studies and patient-centered outcomes research, has become a major healthcare focus. To date, a comprehensive list of genetic counseling outcomes, as espoused by genetic counselors, has not been established and thus, identification of outcomes unique to genetic counseling services has(More)
Raised in a psychosocial model of genetic counseling, I have long believed that understanding and addressing our patients’ psychological needs are critical to our role as genetic counselors. As such, I was pleased to see Biesecker et al.(2016) article, BTheories for psychotherapeutic genetic counseling: Fuzzy trace theory and Cognitive Behavior Theory^ and(More)
Holoprosencephaly (HPE) is a condition characterized by a defect in the development of the midline embryonic forebrain. When detected prenatally, the diagnosis of HPE offers parents a poor but often uncertain prognosis. Since the majority of parents receiving a prenatal diagnosis of an abnormality terminate their pregnancies, few studies have examined(More)
Genetic counselor self-disclosure is a complex behavior that lacks extensive characterization. In particular, data are limited about genetic counselors’ responses when patients ask them to self-disclose. Accordingly, this study investigated genetic counseling students’ (n = 114) and practicing genetic counselors’ (n = 123) responses to two hypothetical(More)
A limited amount of research indicates patient requests play a major role in genetic counselors’ self-disclosure decisions and that disclosure and non-disclosure responses to patient requests may differentially affect genetic counseling processes. Studies further suggest patient requests may be more common in prenatal settings, particularly when counselors(More)
In " An Exploration of Genetic Counselors' Needs and Experiences with Prenatal Chromosomal Microarray Testing, " Bernhardt et al. (2014) investigated the use of chro-mosomal microarray analysis (CMA) in prenatal diagnosis from a unique vantage point—that of the genetic counselor. CMA is just one of the growing number of options for patients on the prenatal(More)
Utilizing the tenet, “Relationship is integral to the genetic counseling process” from the Reciprocal Engagement Model (REM) of genetic counseling practice, this study sought to explore the relationship between the genetic counselor and patient following a “life-limiting” prenatal diagnosis that resulted in a major loss (termination, stillbirth/miscarriage,(More)
Screened for by all state newborn screening (NBS) programs in the United States, mitochondrial acetoacetyl-coenzyme A thiolase (T2), or β-ketothiolase, deficiency is a rare autosomal recessive disorder that causes ketoacidosis and hypoglycemia/hyperglycemia. Outcomes vary from normal development to severe cognitive impairment or even death after an acute(More)
Expanded newborn screening (NBS) for free carnitine levels has led to the identification of a larger number of heterozygous infants of undiagnosed mothers affected with systemic primary carnitine deficiency (PCD), which in turn leads to the identification of other undiagnosed heterozygous family members. There is an increasing recognition that individuals(More)
Newborns identified with profound biotinidase deficiency (BTD) by the Minnesota Newborn Screening Program (MN NBS) between 1 October 2004 and 30 May 2008 were all from new immigrant groups. Thirty-three positive cases of BTD were identified out of 264 727 infants screened by the Wolf colorimetric system during the period of this study by MN NBS. Five cases(More)